The antitumor activity of hPRDX5 against pancreatic cancer and the possible mechanisms

Recombinant human peroxiredoxin-5 (hPRDX5), isolated from anti-cancer bioactive peptide (ACBPs), shows a homology of 89% with goat peroxiredoxin-5 (gPRDX5) and is reported to display anti-tumor activity in vivo. Herein, we explored the effect of hPRDX5 and the responsible mechanism in treating pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Lihua, Jin, Yuanyuan, Zou, Sen, Xun, Jing, Yu, Xiangyang, Zhang, Qi, Yang, Zhaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467283/
https://www.ncbi.nlm.nih.gov/pubmed/36102418
http://dx.doi.org/10.1590/1414-431X2022e12324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467283/
https://www.ncbi.nlm.nih.gov/pubmed/36102418
http://dx.doi.org/10.1590/1414-431X2022e12324

Ejemplares similares